Executive Director, Strategy & Commercial Development, Neuroscience

Role: Executive Director of Neurodegeneration Strategy and Commercial Development, responsible for leading BMS's neurodegeneration portfolio (Alzheimer's, Parkinson's/DLB) from discovery through Phase 3. Responsibilities: develop and execute global strategic plans, oversee pipeline growth, manage market development including biomarker and diagnosis strategies, shape launch preparations, and build relationships with stakeholders. Collaborates with Development, Medical, Regulatory, Commercial, and external partners; leads cross-functional teams and SMG representation. Requirements: BA/BS (life sciences preferred), 12+ years in industry with track record across pipeline stages, experience in Alzheimer's and movement disorders preferred, strong scientific and commercial acumen, and leadership capabilities. Preferred: MBA or advanced degree, US/global experience, and knowledge of drug development, market access, and stakeholder engagement. HighValue: neurodegenerative conditions, early- to mid-stage assets, global strategic leadership, biomarker and diagnosis strategy, stakeholder engagement, and a role operating within a fast-paced, matrix environment. WorkSetup: travel ~20%, location details not specified.